Bern Daily Press
SEE OTHER BRANDS

Your daily news update on Switzerland

Bern Daily Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bern Daily Press.

Press releases published on August 28, 2025

ORIGYN Surpasses $51.3M in Certified Real-World Assets On-Chain

ORIGYN Surpasses $51.3M in Certified Real-World Assets On-Chain

ORIGYN’s TVL has reached another milestone of $51.3 million, a powerful signal of growing trust, adoption, and validation of certified RWA on-chain. NEUCHâTEL, SWITZERLAND, August 28, 2025 /⁨EINPresswire.com⁩/ -- ORIGYN, the protocol dedicated to …

Le Dictionnaire Idéal s’impose comme la nouvelle référence éducative : déjà adopté dans 40 pays depuis son lancement

Le Dictionnaire Idéal s’impose comme la nouvelle référence éducative : déjà adopté dans 40 pays depuis son lancement

Un dictionnaire conçu pour les besoins concrets des élèves, mais aussi des adultes d’aujourd’hui, à la portée internationale avec 20 langues disponibles. PARIS, FRANCE, August 28, 2025 /⁨EINPresswire.com⁩/ -- Lancé il y a à peine deux mois, et disponible …

SECO annuncia Clea OS 2.0

SECO annuncia Clea OS 2.0

Supporto a lungo termine e cybersecurity avanzata per la prossima generazione di dispositivi smart AREZZO, ITALY, August 28, 2025 /⁨EINPresswire.com⁩/ -- SECO S.p.A. (“SECO” o la “Società”) lancia Clea OS v.2.0, un’importante evoluzione del proprio …

WISeKey’s WISeSat Subsidiary Expand its Ground Segment Network in Switzerland

WISeKey’s WISeSat Subsidiary Expand its Ground Segment Network in Switzerland

WISeKey’s WISeSat Subsidiary Expand its Ground Segment Network in Switzerland Lausanne, Switzerland – August 28, 2025 - WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, …

OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole

OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole

Zurich, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AirConsole, the pioneering in-car gaming platform that transforms car rides into shared entertainment experiences, is arriving in the new Porsche Macan later this year. This collaboration will bring a curated …

TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation

TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation

TT125-802 is a small molecule CBP/p300 bromodomain inhibitor that shows clinical activity as single agent in solid tumors, including advanced EGFR-mutated and KRAS-G12C-mutated non-small cell lung cancer (NSCLC) 1 in 5 cancer-related deaths in the US are …

Oculis to Participate in Upcoming September Investor Conferences

Oculis to Participate in Upcoming September Investor Conferences

ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet …

Ascom and AvaSure partner in AI-powered virtual nursing solutions for North America

Ascom and AvaSure partner in AI-powered virtual nursing solutions for North America

Baar, Switzerland, August 28, 2025 Ascom, a leading provider of clinical workflow and mobile communication solutions, and AvaSure, a leader in AI-powered virtual care, have signed a multi-year Interoperability Partner Agreement to integrate AvaSure’s …

Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension

Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension

Allschwil, Switzerland – August 28, 2025 Idorsia Ltd (SIX: IDIA) releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – fits into the treatment landscape for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions